
Rila Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: people who want compounded semaglutide or tirzepatide month to month, with no charge unless prescribed
Rila scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
Price checked on Rila’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Rila is a Utah telehealth company that sells compounded semaglutide and tirzepatide as weekly injections or dissolving tablets, prescribed through the Dr. TelX medical group and filled by three named pharmacies. Monthly plans cost $249 for semaglutide injections and $349 for tirzepatide injections. The advertised $198 is the monthly average of a 6-month plan, and you are not charged unless a provider prescribes.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Rila
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Rila at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $249/mo (3, 6 and 12-month plans cost $639, $1,188 and $2,196 ($213, $198 and $183 a month))
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Rila
Each dimension is scored algorithmically from Rila’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.3/10At $249/mo, Rila runs about 39% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
8.3/10Rila offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.5/10Online intake and platform experience (consult included in the price); 7 platform features disclosed.
Trust & Safety15%
7.4/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.6/10Rila's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.0/10Rila provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Rila review
Last checked October 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $249–$349/mo across 4 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Rila
We walked Rila’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Every Get started button opens the same intake, preset to tirzepatide injections
- 2Pick a primary health goal, then the main reason you want to make a change
- 3Enter your date of birth (18 or older), then your sex at birth
- 4An account screen asks for an email address before the health questions and plan prices (walk stopped here)
- The main site shows only "from" prices tied to a 6-month commitment; full plan prices sit behind the email step
- Monthly plans cost $249 or $275 for semaglutide and $349 or $303 for tirzepatide, by injection or tablet
- Every plan auto-renews, and the terms describe a monthly billing cycle
- The site says your card is charged only after a provider approves the prescription
- Unlike many similar intakes, it did not ask for a state before the email screen
- Support is offered by phone and email, plus a medical assistant assigned to each patient
- We did not take the medication; nothing here describes a patient outcome
Rila customer support
- Phone
- +1 (801) 210-9432
GLP-1 medications Rila offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
3, 6 and 12-month plans cost $639, $1,188 and $2,196 ($213, $198 and $183 a month)
3, 6 and 12-month plans cost $705, $1,000 and $2,419.44
3, 6 and 12-month plans cost $849, $1,589 and $2,988 ($283, $265 and $249 a month)
3, 6 and 12-month plans cost $783, $1,456 and $2,694.60
Ready to get started?
Plans and promotions change often, so check Rila's current pricing and active discounts before you decide.
What we like
- You are not charged unless a licensed provider reviews your answers and prescribes treatment
- Offers semaglutide and tirzepatide, each as a weekly injection or a dissolving tablet
- Names its medical group and all three dispensing pharmacies, with addresses, on its site
- Publishes which states get online-only care and which require a live visit first
- A certified medical assistant is assigned to each patient at no extra cost
- Shipping is free and arrives in discreet packaging
- Support is available by phone as well as email, and FSA or HSA cards are accepted
Watch-outs
- The advertised $198 is the monthly average of a 6-month semaglutide plan; month-to-month starts at $249
- The "from $217" tablet price does not match any plan we could find in the checkout data
- Full plan prices appear only after you enter an email address in the intake
- Charges are non-refundable once a billing cycle starts, and you must cancel 72 hours before renewal
- Kansas, Louisiana, Mississippi, New Mexico, Rhode Island, West Virginia and DC require a live consultation first
- The brand is new and has no independent customer reviews yet
Is Rila worth it?
Rila is aimed squarely at people who want compounded semaglutide or tirzepatide month to month, with no charge unless prescribed. It runs $249/month, a premium versus the rest of the category, so its specific extras need to earn the difference. Its standout is a needle-free oral option for people who would rather not inject.
On top of the core program, it takes HSA/FSA payment and is LegitScript-certified.
How much Rila costs
Compounded semaglutide runs $249–$275/month depending on plan and compounded tirzepatide runs $303–$349/month depending on plan.
For context, the median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide) is around $179/month. Rila's standing rate sits at the premium end of that range, well above the cheapest options in the category.
For a direct comparison, Belle Health runs semaglutide and tirzepatide from $199/month, so compare it with Rila before you commit.
Medications: what Rila prescribes
Rila prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Rila's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who Rila is best for, and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
Look elsewhere if you…
- want the lowest total cost over 6–12 months, where a flat-rate provider like altRX will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Rila costs more than the budget end of the market, so it makes the most sense if its specific extras (the oral option especially) matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, RxSpan MD is one of the closest alternatives we track; compare the two before deciding. To see Rila against the wider field, use our ranked semaglutide providers; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.
The Bottom Line
Rila scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Rila?
From $249/mo. See current pricing and start your free consultation.
Rila might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Rila vs…
Rila scores7.1/10
Side-by-side pricing, medications and scores. Pick a matchup.
Rila vs Amazon One Medical
Amazon One Medical scores 8.5/10

Rila vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Rila review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Rila's current pricing
Plans from $249/mo. Start your free consultation to check eligibility and today's price.